Evidence map›Paper›PMID 36313588›Full record

ArticleClinical pathology (Thousand Oaks, Ventura County, Calif.)

Phosphaturic mesenchymal tumor in right thigh: 2 cases report and literature review.

Ruifeng Wang, Jiayu Zhou, Yupei Yu, Junqi Deng, Ze Wu, Chunlin Ou, Yanhao Wu, Keda Yang, Junpu Wang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical pathology (Thousand Oaks, Ventura County, Calif.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Sinonasal Phosphaturic Mesenchymal Tumor: A Case Report.Turkish archives of otorhinolaryngology · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruifeng WangDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.
Jiayu ZhouDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.
Yupei YuDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.
Junqi DengDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.
Ze WuDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.
Chunlin OuDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.
Yanhao WuDepartment of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Keda YangDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.
Junpu WangDepartment of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Phosphaturic mesenchymal tumor (PMT) is a very rare tumor of bone and soft tissue that has no specific clinical manifestations. Here we present 2 cases of PMT in the right thigh, including comparatively adequate immunohistochemistry. Case Presentation: We described 2 cases of PMT in the right thigh with manifestations of hypophosphatemia. PET-CT examination showed that both patients had lesions with increased expression of somatostatin receptors in the right thigh. Bland cells and dirty calcified stroma were exhibited under the microscope. And immunohistochemical detection of FGF-23 was positive. Conclusions: PMT is a very uncommon tumor for which diagnosis and treatment are often delayed. Considering the importance of surgery for the treatment of this disease, a full understanding of its clinicopathological features will facilitate the diagnosis of this disease.

Indexed as

FGF-23pathologyPhosphaturic mesenchymal tumorthightumor-induced osteomalacia

Identifiers

PMID36313588
PMCPMC9597019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.